Chemocentryx Stock Performance

CCXI -  USA Stock  

USD 24.14  1.32  5.18%

The firm shows a Beta (market volatility) of 2.0603, which signifies a somewhat significant risk relative to the market. Let's try to break down what Chemocentryx's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Chemocentryx will likely underperform. Even though it is essential to pay attention to Chemocentryx historical returns, it is always good to be careful when utilizing equity current trending patterns. Our philosophy in foreseeing any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Chemocentryx exposes twenty-eight different technical indicators, which can help you to evaluate its performance. Chemocentryx has an expected return of -0.53%. Please be advised to confirm Chemocentryx maximum drawdown, and the relationship between the information ratio and expected short fall to decide if Chemocentryx performance from the past will be repeated at some point in the near future.

Chemocentryx Stock Performance 

 
Refresh
Chemocentryx Performance
0 of 100
Over the last 90 days Chemocentryx has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2022. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more

Chemocentryx Price Channel

Quick Ratio4.82
Fifty Two Week Low9.53
Target High Price110.00
Fifty Two Week High70.29
Target Low Price40.00

Chemocentryx Relative Risk vs. Return Landscape

If you would invest  3,481  in Chemocentryx on October 29, 2021 and sell it today you would lose (1,067)  from holding Chemocentryx or give up 30.65% of portfolio value over 90 days. Chemocentryx is currently does not generate positive expected returns and assumes 3.4845% risk (volatility on return distribution) over the 90 days horizon. In different words, 29% of stocks are less volatile than Chemocentryx, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
 Daily Expected Return (%) 
      Risk (%) 
Given the investment horizon of 90 days Chemocentryx is expected to under-perform the market. In addition to that, the company is 4.13 times more volatile than its market benchmark. It trades about -0.15 of its total potential returns per unit of risk. The DOW is currently generating roughly -0.09 per unit of volatility.

Chemocentryx Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Chemocentryx's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Chemocentryx, and traders can use it to determine the average amount a Chemocentryx's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.1515

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsCCXI
Estimated Market Risk
 3.48
  actual daily
 
 29 %
of total potential
 
2929
Expected Return
 -0.53
  actual daily
 
 0 %
of total potential
 
00
Risk-Adjusted Return
 -0.15
  actual daily
 
 0 %
of total potential
 
00
Based on monthly moving average Chemocentryx is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Chemocentryx by adding it to a well-diversified portfolio.

About Chemocentryx Performance

To evaluate Chemocentryx Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Chemocentryx generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Chemocentryx Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Chemocentryx stock market performance in a much more refined way. At Macroaxis, we take it even further. The Macroaxis performance score is an integer between 0 and 100 that represents Chemocentryx's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Return on Investment(25.60) (27.62) 
Return on Average Assets(0.14) (0.15) 
Return on Average Equity(0.16) (0.18) 
Return on Invested Capital(0.19) (0.21) 
Return on Sales(0.93) (1.01) 
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in San Carlos, California. Chemocentryx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 133 people.

Things to note about Chemocentryx

Checking the ongoing alerts about Chemocentryx for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Chemocentryx help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Chemocentryx Alerts

Equity Alerts and Improvement Suggestions

Chemocentryx generated a negative expected return over the last 90 days
Chemocentryx has high historical volatility and very poor performance
The company reported the previous year's revenue of 34.27 M. Net Loss for the year was (121.1 M) with loss before overhead, payroll, taxes, and interest of (12.99 M).
Chemocentryx currently holds about 269.43 M in cash with (83.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.85.
Chemocentryx has a frail financial position based on the latest SEC disclosures
Roughly 65.0% of the company shares are held by institutions such as insurance companies
Latest headline from www.bakersfield.com: VFMCRP receives EU approval for Tavneos for the treatment of ANCA-associated vasculitis - The Bakersfield Californian
Continue to Trending Equities. Note that the Chemocentryx information on this page should be used as a complementary analysis to other Chemocentryx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bond Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for Chemocentryx Stock analysis

When running Chemocentryx price analysis, check to measure Chemocentryx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemocentryx is operating at the current time. Most of Chemocentryx's value examination focuses on studying past and present price action to predict the probability of Chemocentryx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chemocentryx's price. Additionally, you may evaluate how the addition of Chemocentryx to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Is Chemocentryx's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemocentryx. If investors know Chemocentryx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemocentryx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Chemocentryx is measured differently than its book value, which is the value of Chemocentryx that is recorded on the company's balance sheet. Investors also form their own opinion of Chemocentryx's value that differs from its market value or its book value, called intrinsic value, which is Chemocentryx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemocentryx's market value can be influenced by many factors that don't directly affect Chemocentryx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemocentryx's value and its price as these two are different measures arrived at by different means. Investors typically determine Chemocentryx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemocentryx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.